Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.5%

2 terminated/withdrawn out of 44 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

18%

8 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed trials have results

Key Signals

12 recruiting1 with results

Enrollment Performance

Analytics

N/A
9(47.4%)
Phase 4
5(26.3%)
Phase 3
3(15.8%)
Phase 1
1(5.3%)
Phase 2
1(5.3%)
19Total
N/A(9)
Phase 4(5)
Phase 3(3)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (44)

Showing 20 of 44 trials
NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT07453420Active Not Recruiting

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.

Role: collaborator

NCT07455097Active Not Recruiting

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

Role: collaborator

NCT07432347Recruiting

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

Role: collaborator

NCT07390903Recruiting

GLS in Difficult CPB Weaning

Role: collaborator

NCT07262957Phase 4Recruiting

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Role: collaborator

NCT07213531Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Role: collaborator

NCT07120152Not Yet Recruiting

A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease

Role: collaborator

NCT07092826Active Not Recruiting

Obsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum Disorders

Role: collaborator

NCT07065825Not Yet Recruiting

Tumor Rupture During Robotic Partial Nephrectomy

Role: collaborator

NCT06475456Recruiting

Pilot Italian Cardiogenic Shock Initiative

Role: collaborator

NCT06099119Phase 4Recruiting

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Role: collaborator

NCT03270917Not ApplicableActive Not Recruiting

ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection

Role: collaborator

NCT01441856Not ApplicableCompleted

The ORANGE II PLUS - Trial: Open Versus Laparoscopic Hemihepatectomy

Role: collaborator

NCT06680674Active Not Recruiting

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Role: collaborator

NCT03461497Active Not Recruiting

Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery

Role: collaborator

NCT05360264Phase 2Terminated

tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr

Role: collaborator

NCT06884631Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Role: collaborator

NCT06805812Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Role: collaborator

NCT02815566Phase 4Completed

Bone Health in Aging HIV Infected Women

Role: collaborator